{{Rsnum
|rsid=1799801
|Gene=ERCC4
|Chromosome=16
|position=13948101
|Orientation=plus
|GMAF=0.2264
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ERCC4
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 8.8 | 30.1 | 61.1
| HCB | 5.1 | 37.2 | 57.7
| JPT | 11.5 | 40.7 | 47.8
| YRI | 0.0 | 18.4 | 81.6
| ASW | 0.0 | 28.1 | 71.9
| CHB | 5.1 | 37.2 | 57.7
| CHD | 3.7 | 33.0 | 63.3
| GIH | 6.9 | 46.5 | 46.5
| LWK | 4.6 | 37.6 | 57.8
| MEX | 8.6 | 25.9 | 65.5
| MKK | 11.5 | 47.4 | 41.0
| TSI | 11.9 | 32.7 | 55.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=21622940
|Title=Single Nucleotide Polymorphisms in DNA Repair Genes and Association with Breast Cancer Risk in the WEB Study
|OA=1
}}

{{PMID Auto
|PMID=22768293
|Title=Association between XPF Polymorphisms and Cancer Risk: A Meta-Analysis
|OA=1
}}

{{PMID|17299578|OA=1
}} Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a meta-analysis.

{{PMID|19706757|OA=1
}} Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer.

{{PMID Auto
|PMID=24353636
|Title=Effect of Xeroderma pigmentosum complementation group F polymorphisms and H.pylori infection on the risk of gastric cancer
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}